|
 |
|
|
|||
|
 |
|
Feb. 18, 2016 Source: FLM+ news release FLM+, a hybrid strategic consulting, marketing and communications company, has been awarded public relations responsibilities for two groups within Boehringer Ingelheim Vetmedica Inc. (BIVI). FLM+ will provide PR strategy and executional support for the U.S. Pet and Corporate groups. "FLM+ was clearly the right choice for this work," said Lorie North, director of marketing, Pet. "We were impressed by the team's creativity, strategic thinking and overall depth of knowledge about our business." FLM+ was selected by BIVI following a competitive agency review process. The agreement between BIVI and FLM+ takes effect immediately. "This is an incredibly important assignment for FLM+," says Rob McClelland, FLM+ president/CEO. "We have been focused on earning business in the animal health sector, and with our team's deep experience across all species, we are honored, excited and ready to get to work with BIVI." The core FLM+ team supporting BIVI is based in Kansas City, Mo., in close proximity to BIVI U.S. headquarters in St. Joseph, Mo. FLM+ team members from other offices will provide support. About Boehringer Ingelheim Vetmedica, Inc. Boehringer Ingelheim Vetmedica, Inc., (BIVI) is the fifth largest animal health company in the U.S. and produces innovative vaccine and pharmaceutical products for the prevention and treatment of diseases in the swine, cattle, equine and companion animal markets. BIVI is the U.S. subsidiary of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other locations in Ames, Fort Dodge and Sioux Center, Iowa. With more than 3,600 employees worldwide, Boehringer Ingelheim Animal Health achieved net sales of about 1.13 billion euros in 2014. In our research-driven Animal Health business, Boehringer Ingelheim continually invests more than 11% of net sales of the Animal Health business in R&D. The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146 affiliates and a total of more than 47,700 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative "Making more Health" and caring for the employees. Respect, equal opportunities and reconciling career and family form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability. For more information please visit www.bi-vetmedica.com About FLM+ FLM+ is dedicated to bringing wide open thinking, engaging content and specialized thought leadership to global clients that specialize in agriculture and life and environmental sciences to improve the lives and health of plants, animals, people and communities. The FLM+ team is passionate about delivering world class work that produces far-reaching results by setting strategies, aligning teams, framing opinions and creating demand. FLM+ team members are located in Minneapolis; Columbus, Ohio; Kansas City, Mo.; Washington, D.C.; Indianapolis; Chicago; Sioux Falls, S.D.; and East Lansing, Mich. Tweet |
|
|
|
|
|
|
|
|
|||||||||||||
